Teladoc Health Inc has a consensus price target of $18.6 based on the ratings of 33 analysts. The high is $40 issued by DA Davidson on October 25, 2022. The low is $8 issued by B of A Securities on April 11, 2025. The 3 most-recent analyst ratings were released by B of A Securities, Goldman Sachs, and Piper Sandler on April 11, 2025, March 3, 2025, and February 27, 2025, respectively. With an average price target of $11 between B of A Securities, Goldman Sachs, and Piper Sandler, there's an implied 52.99% upside for Teladoc Health Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/11/2025 | Buy Now | 11.27% | B of A Securities | Allen Lutz62% | $9.5 → $8 | Maintains | Neutral | Get Alert |
03/03/2025 | Buy Now | 80.81% | Goldman Sachs | David Roman35% | $16 → $13 | Maintains | Buy | Get Alert |
02/27/2025 | Buy Now | — | Needham | Ryan MacDonald57% | — | Reiterates | Hold → Hold | Get Alert |
02/27/2025 | Buy Now | 66.9% | Piper Sandler | Jessica Tassan41% | $13 → $12 | Maintains | Overweight | Get Alert |
02/18/2025 | Buy Now | 122.53% | Goldman Sachs | David Roman35% | $14 → $16 | Maintains | Buy | Get Alert |
02/12/2025 | Buy Now | 87.76% | B of A Securities | Allen Lutz62% | $11.5 → $13.5 | Maintains | Neutral | Get Alert |
02/06/2025 | Buy Now | 59.94% | B of A Securities | Allen Lutz62% | $10.5 → $11.5 | Maintains | Neutral | Get Alert |
01/24/2025 | Buy Now | 66.9% | RBC Capital | Sean Dodge48% | $11 → $12 | Maintains | Outperform | Get Alert |
01/24/2025 | Buy Now | 66.9% | Oppenheimer | Michael Wiederhorn63% | $14 → $12 | Maintains | Outperform | Get Alert |
12/04/2024 | Buy Now | 80.81% | Piper Sandler | Jessica Tassan41% | $11 → $13 | Reiterates | Overweight → Overweight | Get Alert |
11/15/2024 | Buy Now | 94.71% | Goldman Sachs | David Roman35% | → $14 | Initiates | → Buy | Get Alert |
11/01/2024 | Buy Now | 66.9% | Deutsche Bank | George Hill64% | $10 → $12 | Maintains | Hold | Get Alert |
10/31/2024 | Buy Now | 66.9% | Barclays | Steve Valiquette55% | $10 → $12 | Maintains | Overweight | Get Alert |
10/31/2024 | Buy Now | 11.27% | TD Cowen | Charles Rhyee37% | $9 → $8 | Maintains | Hold | Get Alert |
10/09/2024 | Buy Now | 39.08% | RBC Capital | Sean Dodge48% | $9 → $10 | Maintains | Outperform | Get Alert |
10/08/2024 | Buy Now | 25.17% | Evercore ISI Group | Elizabeth Anderson45% | $8 → $9 | Maintains | In-Line | Get Alert |
09/17/2024 | Buy Now | 39.08% | Jefferies | Glen Santangelo50% | $8 → $10 | Maintains | Hold | Get Alert |
08/26/2024 | Buy Now | 25.17% | JP Morgan | Lisa Gill60% | $16 → $9 | Maintains | Neutral | Get Alert |
08/20/2024 | Buy Now | 39.08% | Cantor Fitzgerald | Sarah James53% | $10 → $10 | Reiterates | Overweight → Overweight | Get Alert |
08/06/2024 | Buy Now | 39.08% | Piper Sandler | Jessica Tassan41% | $25 → $10 | Maintains | Overweight | Get Alert |
08/02/2024 | Buy Now | 39.08% | Deutsche Bank | George Hill64% | $15 → $10 | Maintains | Hold | Get Alert |
08/02/2024 | Buy Now | 39.08% | Truist Securities | Jailendra Singh38% | $15 → $10 | Maintains | Hold | Get Alert |
08/01/2024 | Buy Now | — | Needham | Ryan MacDonald57% | — | Reiterates | → Hold | Get Alert |
08/01/2024 | Buy Now | 25.17% | TD Cowen | Charles Rhyee37% | $15 → $9 | Maintains | Hold | Get Alert |
08/01/2024 | Buy Now | 25.17% | RBC Capital | Sean Dodge48% | $18 → $9 | Maintains | Outperform | Get Alert |
08/01/2024 | Buy Now | 39.08% | Barclays | Steve Valiquette55% | $20 → $10 | Maintains | Overweight | Get Alert |
08/01/2024 | Buy Now | 25.17% | Stifel | David Grossman62% | $16 → $9 | Maintains | Hold | Get Alert |
08/01/2024 | Buy Now | 11.27% | DA Davidson | Gil Luria49% | $12 → $8 | Maintains | Neutral | Get Alert |
08/01/2024 | Buy Now | 136.44% | Canaccord Genuity | Richard Close46% | $25 → $17 | Maintains | Buy | Get Alert |
08/01/2024 | Buy Now | 136.44% | Oppenheimer | Michael Wiederhorn63% | $21 → $17 | Maintains | Outperform | Get Alert |
07/09/2024 | Buy Now | 39.08% | Evercore ISI Group | Elizabeth Anderson45% | $14 → $10 | Maintains | In-Line | Get Alert |
05/21/2024 | Buy Now | 122.53% | JP Morgan | Lisa Gill60% | $19 → $16 | Maintains | Neutral | Get Alert |
05/20/2024 | Buy Now | 94.71% | Jefferies | Glen Santangelo50% | $16 → $14 | Maintains | Hold | Get Alert |
05/14/2024 | Buy Now | 87.76% | B of A Securities | Allen Lutz62% | $16.5 → $13.5 | Maintains | Neutral | Get Alert |
04/29/2024 | Buy Now | 108.62% | Wells Fargo | Stephen Baxter58% | $17 → $15 | Maintains | Equal-Weight | Get Alert |
04/26/2024 | Buy Now | 192.07% | Oppenheimer | Michael Wiederhorn63% | $26 → $21 | Maintains | Outperform | Get Alert |
04/26/2024 | Buy Now | 108.62% | TD Cowen | Charles Rhyee37% | $16 → $15 | Maintains | Hold | Get Alert |
04/26/2024 | Buy Now | 94.71% | Evercore ISI Group | — | $15 → $14 | Maintains | In-Line | Get Alert |
04/26/2024 | Buy Now | 150.35% | RBC Capital | Sean Dodge48% | $25 → $18 | Maintains | Outperform | Get Alert |
04/26/2024 | Buy Now | 122.53% | Stifel | David Grossman62% | $21 → $16 | Maintains | Hold | Get Alert |
04/26/2024 | Buy Now | 178.16% | Barclays | Steve Valiquette55% | $25 → $20 | Maintains | Overweight | Get Alert |
04/26/2024 | Buy Now | 247.71% | Canaccord Genuity | Richard Close46% | $28 → $25 | Maintains | Buy | Get Alert |
04/26/2024 | Buy Now | — | Needham | Ryan MacDonald57% | — | Reiterates | → Hold | Get Alert |
04/05/2024 | Buy Now | — | Needham | Ryan MacDonald57% | — | Reiterates | → Hold | Get Alert |
03/06/2024 | Buy Now | 136.44% | Truist Securities | Jailendra Singh38% | $23 → $17 | Maintains | Hold | Get Alert |
02/29/2024 | Buy Now | 205.98% | Cantor Fitzgerald | Sarah James53% | → $22 | Initiates | → Overweight | Get Alert |
02/26/2024 | Buy Now | 136.44% | Leerink Partners | Michael Cherny79% | → $17 | Initiates | → Market Perform | Get Alert |
02/21/2024 | Buy Now | 150.35% | DA Davidson | Gil Luria49% | $22 → $18 | Maintains | Neutral | Get Alert |
02/21/2024 | Buy Now | 164.26% | Citigroup | Daniel Grosslight44% | $21 → $19 | Maintains | Neutral | Get Alert |
02/21/2024 | Buy Now | 247.71% | RBC Capital | Sean Dodge48% | $30 → $25 | Maintains | Outperform | Get Alert |
02/21/2024 | Buy Now | 247.71% | Barclays | Steve Valiquette55% | $26 → $25 | Maintains | Overweight | Get Alert |
02/21/2024 | Buy Now | 247.71% | Piper Sandler | Jessica Tassan41% | $30 → $25 | Maintains | Overweight | Get Alert |
02/21/2024 | Buy Now | 289.43% | Canaccord Genuity | Richard Close46% | $34 → $28 | Maintains | Buy | Get Alert |
11/17/2023 | Buy Now | 164.26% | JP Morgan | Lisa Gill60% | $33 → $19 | Maintains | Neutral | Get Alert |
10/25/2023 | Buy Now | 317.25% | RBC Capital | Sean Dodge48% | $35 → $30 | Maintains | Outperform | Get Alert |
10/25/2023 | Buy Now | 261.61% | Oppenheimer | Michael Wiederhorn63% | $35 → $26 | Maintains | Outperform | Get Alert |
10/23/2023 | Buy Now | 192.07% | Citigroup | Daniel Grosslight44% | $29 → $21 | Maintains | Neutral | Get Alert |
10/20/2023 | Buy Now | 192.07% | Citigroup | Daniel Grosslight44% | $29 → $21 | Maintains | Neutral | Get Alert |
09/25/2023 | Buy Now | 289.43% | Truist Securities | Jailendra Singh38% | → $28 | Reiterates | Hold → Hold | Get Alert |
07/26/2023 | Buy Now | 289.43% | Stephens & Co. | Jeff Garro38% | → $28 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
07/26/2023 | Buy Now | 386.79% | RBC Capital | Sean Dodge48% | → $35 | Reiterates | Outperform → Outperform | Get Alert |
07/26/2023 | Buy Now | 303.34% | Citigroup | Daniel Grosslight44% | $31 → $29 | Maintains | Neutral | Get Alert |
07/26/2023 | Buy Now | 275.52% | Credit Suisse | Jonathan Yong66% | → $27 | Reiterates | Neutral → Neutral | Get Alert |
04/28/2023 | Buy Now | 303.34% | Deutsche Bank | George Hill64% | $27 → $29 | Maintains | Hold | Get Alert |
04/27/2023 | Buy Now | 331.15% | Citigroup | Daniel Grosslight44% | $30 → $31 | Maintains | Neutral | Get Alert |
04/27/2023 | Buy Now | 386.79% | RBC Capital | Sean Dodge48% | → $35 | Reiterates | → Outperform | Get Alert |
04/27/2023 | Buy Now | 275.52% | Credit Suisse | Jonathan Yong66% | → $27 | Reiterates | → Neutral | Get Alert |
04/27/2023 | Buy Now | 303.34% | Barclays | Steve Valiquette55% | $28 → $29 | Maintains | Equal-Weight | Get Alert |
04/12/2023 | Buy Now | 247.71% | Stephens & Co. | Jeff Garro38% | → $25 | Initiates | → Equal-Weight | Get Alert |
03/10/2023 | Buy Now | 275.52% | Credit Suisse | Jonathan Yong66% | $30 → $27 | Maintains | Neutral | Get Alert |
03/06/2023 | Buy Now | 400.7% | Canaccord Genuity | Richard Close46% | $40 → $36 | Maintains | Buy | Get Alert |
03/06/2023 | Buy Now | 219.89% | Wells Fargo | Stan Berenshteyn40% | $28 → $23 | Maintains | Equal-Weight | Get Alert |
02/28/2023 | Buy Now | 317.25% | Citigroup | Daniel Grosslight44% | $33 → $30 | Maintains | Neutral | Get Alert |
02/27/2023 | Buy Now | 275.52% | Deutsche Bank | George Hill64% | $31 → $27 | Maintains | Hold | Get Alert |
02/27/2023 | Buy Now | 358.97% | JP Morgan | Lisa Gill60% | $35 → $33 | Maintains | Neutral | Get Alert |
02/23/2023 | Buy Now | 386.79% | Oppenheimer | Michael Wiederhorn63% | $37 → $35 | Maintains | Outperform | Get Alert |
02/23/2023 | Buy Now | 386.79% | RBC Capital | Sean Dodge48% | → $35 | Reiterates | → Outperform | Get Alert |
02/23/2023 | Buy Now | 372.88% | SVB Leerink | Stephanie Davis41% | → $34 | Upgrade | Market Perform → Outperform | Get Alert |
01/19/2023 | Buy Now | 414.6% | Oppenheimer | Colin Rusch53% | $45 → $37 | Maintains | Outperform | Get Alert |
01/18/2023 | Buy Now | 289.43% | Barclays | Marc Solecitto60% | $32 → $28 | Maintains | Equal-Weight | Get Alert |
12/13/2022 | Buy Now | 358.97% | Citigroup | Daniel Grosslight44% | $36 → $33 | Maintains | Neutral | Get Alert |
10/31/2022 | Buy Now | 317.25% | Credit Suisse | Jonathan Yong66% | $35 → $30 | Maintains | Neutral | Get Alert |
10/27/2022 | Buy Now | 400.7% | Citigroup | Daniel Grosslight44% | $38 → $36 | Maintains | Neutral | Get Alert |
10/27/2022 | Buy Now | 345.06% | Barclays | Steve Valiquette55% | $33 → $32 | Maintains | Equal-Weight | Get Alert |
10/25/2022 | Buy Now | 456.33% | DA Davidson | Robert Simmons53% | $45 → $40 | Maintains | Buy | Get Alert |
10/24/2022 | Buy Now | — | Guggenheim | Sandy Draper73% | — | Upgrade | Sell → Neutral | Get Alert |
10/21/2022 | Buy Now | 303.34% | Truist Securities | Jailendra Singh38% | $35 → $29 | Maintains | Hold | Get Alert |
10/11/2022 | Buy Now | 358.97% | Barclays | Steve Valiquette55% | $40 → $33 | Maintains | Equal-Weight | Get Alert |
09/28/2022 | Buy Now | 386.79% | RBC Capital | Sean Dodge48% | $53 → $35 | Maintains | Outperform | Get Alert |
09/27/2022 | Buy Now | 331.15% | Deutsche Bank | George Hill64% | $34 → $31 | Maintains | Hold | Get Alert |
09/16/2022 | Buy Now | — | Keybanc | Scott Schoenhaus41% | — | Initiates | → Sector Weight | Get Alert |
09/07/2022 | Buy Now | 386.79% | Truist Securities | Jailendra Singh38% | → $35 | Initiates | → Hold | Get Alert |
08/17/2022 | Buy Now | 247.71% | Guggenheim | Sandy Draper73% | → $25 | Downgrade | Neutral → Sell | Get Alert |
08/12/2022 | Buy Now | 525.87% | DA Davidson | Robert Simmons53% | → $45 | Initiates | → Buy | Get Alert |
08/02/2022 | Buy Now | 386.79% | Berenberg | Ravi Misra34% | $42 → $35 | Downgrade | Buy → Hold | Get Alert |
08/02/2022 | Buy Now | 372.88% | Cowen & Co. | Charles Rhyee37% | $58 → $34 | Downgrade | Outperform → Market Perform | Get Alert |
07/28/2022 | Buy Now | 400.7% | Goldman Sachs | Cindy Motz29% | $55 → $36 | Downgrade | Buy → Neutral | Get Alert |
07/28/2022 | Buy Now | 456.33% | Barclays | Steve Valiquette55% | $42 → $40 | Maintains | Equal-Weight | Get Alert |
07/28/2022 | Buy Now | — | Needham | Ryan MacDonald57% | — | Downgrade | Buy → Hold | Get Alert |
07/28/2022 | Buy Now | 456.33% | Piper Sandler | Jessica Tassan41% | $42 → $40 | Maintains | Overweight | Get Alert |
The latest price target for Teladoc Health (NYSE:TDOC) was reported by B of A Securities on April 11, 2025. The analyst firm set a price target for $8.00 expecting TDOC to rise to within 12 months (a possible 11.27% upside). 43 analyst firms have reported ratings in the last year.
The latest analyst rating for Teladoc Health (NYSE:TDOC) was provided by B of A Securities, and Teladoc Health maintained their neutral rating.
The last upgrade for Teladoc Health Inc happened on February 23, 2023 when SVB Leerink raised their price target to $34. SVB Leerink previously had a market perform for Teladoc Health Inc.
The last downgrade for Teladoc Health Inc happened on August 17, 2022 when Guggenheim changed their price target from N/A to $25 for Teladoc Health Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Teladoc Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Teladoc Health was filed on April 11, 2025 so you should expect the next rating to be made available sometime around April 11, 2026.
While ratings are subjective and will change, the latest Teladoc Health (TDOC) rating was a maintained with a price target of $9.50 to $8.00. The current price Teladoc Health (TDOC) is trading at is $7.19, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.